alexa In vitro effect of DNA topoisomerase inhibitors on Candida albicans.
Pharmaceutical Sciences

Pharmaceutical Sciences

Journal of Developing Drugs

Author(s): Kwok SC, Schelenz S, Wang X, Steverding D

Abstract Share this page

Abstract In this study we investigated the in vitro antifungal activity of 10 DNA topoisomerase inhibitors on the growth of Candida albicans. The EUCAST broth microdilution method was used to determine the minimum inhibitory concentrations (MICs) of the compounds for C. albicans. In addition, the effect of the inhibitors on the growth mode of C. albicans was investigated by light microscopy imaging. Of the 10 DNA topoisomerase inhibitors tested, only the anti-cancer drug aclarubicin displayed antifungal activity with a determinable MIC value of 8.4 microg/ml (10.3 microM). Aclarubicin was also active against clinical isolates of C. albicans with MIC values ranging between 0.8 and 7.3 microg/ml (1-9 microM). Vitality assays showed that the action of aclarubicin was fungistatic. Four other DNA topoisomerase inhibitors, daunorubicin, doxorubicin, idarubicin and beta-lapachone, affected the morphology of C. albicans. The first three inhibitors encouraged the fungus to grow predominantly in the yeast form, whereas beta-lapachone caused hyphal proliferation. The results of this study indicate that some DNA topoisomerase inhibitors effect the growth and morphology of C. albicans suggesting a possible role as antifungal agents in the treatment of C. albicans infections. This article was published in Med Mycol and referenced in Journal of Developing Drugs

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version